Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2003
11/26/2003EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/26/2003CN1128789C Benzocycloheptathiophene compounds
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128620C Use of levobupivacaine in preparing medicine for treating migraine
11/25/2003US6653512 Halogen compounds such as heptafluoropropyl, chloromethyl ether, used as solvents, cleaning compounds, blowing agents, coolants, lubricants, in fire extinguishers or heat exchangers
11/25/2003US6653482 The ketoaldonic acid methyl ester is converted into the oxime which is then reduced to the amine which cyclizes to give the lactam which is then reduced to the imino sugar by borane or a metal hydride
11/25/2003US6653481 Used as calcium channel blockers
11/25/2003US6653480 Process for the preparation of 1,5-dideoxy-1, 5-imino hexitols from oximes or imines
11/25/2003US6653325 Dyskinesias, by administering a substituted phenylazacycloalkane and a dopamine agonist to the patient
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094853A2 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2003039482A3 Polymorphs of fexofenadine base
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216387 Benzamide derivatives, particularly esterified cisapride derivatives
11/20/2003US20030216383 Compounds useful as reversible inhibitors of cysteine proteases
11/20/2003US20030216380 Novel gamma secretase inhibitors
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/19/2003EP1362849A2 Process for production of piperidine derivatives
11/19/2003EP1362589A1 The use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4- piperidinemethanol for the treatment of sleep disorders
11/19/2003EP1362083A1 Ink-jet ink and recording material
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362032A2 Process of preparing paroxetine and intermediates for use therein
11/19/2003EP1362031A1 Pharmaceutically active piperidine derivatives
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1240141B1 New modulators of dopamine neurotransmission
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003CN1457355A 液晶混合物 Liquid crystal mixtures
11/19/2003CN1128145C Process for preparing piperine
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1127954C Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol for treatment of sleep disorders
11/18/2003US6649767 Contacting an enamine compound with a ketonic compound in presence of a base, treating the reaction mixture thus obtained with an acid or combinations of acids
11/18/2003US6649766 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
11/18/2003US6649765 Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/18/2003US6649642 Succinate derivative compounds useful as cysteine protease inhibitors
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649623 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/18/2003US6649142 Labeled compounds for measuring the function of the muscarinic acetylcholine nervous system
11/18/2003CA2159586C Process for preparing 3-methylpiperidine and 3-methylpyridine by catalytic cyclisation of 2-methyl-1,5-diaminopentane
11/13/2003WO2003093254A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092689A1 The treatment of pain with ifendropil
11/13/2003WO2003092688A2 Heterocyclic derivatives as opioid modulators
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212108 Crystal modification
11/13/2003US20030212076 Anticoagulants; antiischemic agents
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212065 Using a imidazolo(4,5,1-ij)quinoline compound
11/13/2003US20030211999 Polypeptides containing gamma-amino acids
11/13/2003CA2753371A1 Heterocyclic derivatives as opioid receptor modulators
11/13/2003CA2485115A1 The treatment of pain with ifenprodil
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361213A1 Process for preparation of cyanophenylbenzoic acid derivatives
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360177A2 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1359891A2 Primary intermediates for oxidative coloration of hair
11/12/2003EP1208084B1 Tetrahydropyridines as pesticides
11/12/2003EP1019373B1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists
11/12/2003EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof
11/12/2003CN1455771A Cyclic amine phenyl Beta-3 adrenergic receptor agonists
11/12/2003CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/11/2003US6646131 Resolution of the enantiomers of amlodipine
11/11/2003US6646127 Reacting in a liquid phase reaction mixture: A) at least one acetone compound, and B) at least one ammonia donor compound, in presence of crystalline calcium aluminosilicate catalyst to form 2,2,6,6-tetramethyl-4-oxopiperidine (triacetonamine)
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 380